Fintel reports that on January 6, 2025, Leerink Partners upgraded their outlook for Align Technology (NasdaqGS:ALGN) from Market Perform to Outperform. As of December 23, 2024, the average one-year ...
Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of Align Technology (NasdaqGS:ALGN) with a Overweight recommendation. As of January 29, 2025, the average one-year price target ...
Dental technology company Align Technology (NASDAQ:ALGN) in Q2 CY2025, with sales falling 1.6% year on year to $1.01 billion. Next quarter’s revenue guidance of $975 million underwhelmed, coming in ...
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ ...
TEMPE, Ariz.--(BUSINESS WIRE)-- Align Technology, Inc. (ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback